[Results of the surgical treatment of benign hypertrophy of the prostate].
Fourcade
R O
RO
Lanson
Y
Y
Teillac
P
P
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003404:Creatinine / Q000652:urine; D004542:Ejaculation / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011467:Prostate / Q000473:pathology / Q000503:physiopathology / Q000601:surgery; D017430:Prostate-Specific Antigen / Q000032:analysis; D011470:Prostatic Hyperplasia / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D011788:Quality of Life; D012307:Risk Factors; D012723:Sex; D016896:Treatment Outcome; D014554:Urination / Q000502:physiology
D000900:Anti-Bacterial Agents; D003404:Creatinine; D017430:Prostate-Specific Antigen